U.S. FDA Approves IBRANCE for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
Approval of expanded indication based predominately on real-world data NEW YORK–(BUSINESS WIRE)–Pfizer (NYSE:PFE) today announced that the U.S. Food and…
Pharmaceuticals, Biotechnology and Life Sciences
Approval of expanded indication based predominately on real-world data NEW YORK–(BUSINESS WIRE)–Pfizer (NYSE:PFE) today announced that the U.S. Food and…
New module available as a standalone solution or fully integral with AMPLEXOR’s Life Sciences Suite BROOMFIELD, Colo.–(BUSINESS WIRE)–The Life Sciences…
The First HepQuant SHUNT™ Data From An Interventional Drug Study in NASH DENVER–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/NASH?src=hash” target=”_blank”gt;#NASHlt;/agt;–HepQuant, LLC, a Greenwood Village,…
DUBLIN–(BUSINESS WIRE)–The “Global Next Generation Sequencing Market Analysis & Trends – Industry Forecast to 2027” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Global Drug Delivery Technologies Market Analysis & Trends – Industry Forecast to 2027” report has been added to…
MALVERN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/antibiotics?src=hash" target="_blank"gt;#antibioticslt;/agt;–VenatoRx Pharmaceuticals today announced that Lisa Wittmer, Ph.D. has joined the Company as Chief Development Officer.…
WASHINGTON–(BUSINESS WIRE)–Congresswoman Debbie Dingell was recognized today by the Biotechnology Innovation Organization (BIO) for her leadership as an Innovator in…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trial Packaging Market Analysis & Trends – Industry Forecast to 2027” report has been added to…
Roche presents data from a mock clinical trial study suggesting that next-generation discovery proteomics is ready for use in clinical…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that the European Commission has approved VIZIMPRO® (dacomitinib), a tyrosine kinase inhibitor…